Please wait while the formulary information is being retrieved.
GARDASIL 9 (HUMAN PAPILLOMAVIRUS VACCINE, 9-VALENT/PF)
- Prevention of cervical cancer due to HPV
- Prevention of genital warts
- Prevention of anal cancer due to HPV
- Prevention of vaginal cancer due to HPV
- Prevention of vulvar cancer due to HPV
(PF) 0.5 mL intramuscular syringe
- Dosage information is not available
(PF) 0.5 mL intramuscular suspension
- Dosage information is not available
- None
Contraindicated
- fingolimod
- Gilenya
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
GARDASIL 9 (HUMAN PAPILLOMAVIRUS VACCINE, 9-VALENT/PF)
- Prevention of cervical cancer due to HPV
- Prevention of genital warts
- Prevention of anal cancer due to HPV
- Prevention of vaginal cancer due to HPV
- Prevention of vulvar cancer due to HPV
- None
- Erythema
- Headache disorder
- Injection site sequelae
- Pain
More Frequent
Severe
Less Severe
- None
- Bruising
- Dizziness
- Fatigue
- Fever
- Hematoma
- Induration of skin
- Nausea
- Pain in oropharynx
- Pruritus of skin
- Skin swelling
- Upper abdominal pain
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Appendicitis
- Asthma
- Bronchospastic pulmonary disease
- Cellulitis
- Deep venous thrombosis
- Gastroenteritis
- Guillain-barre syndrome
- Idiopathic thrombocytopenic purpura
- Inflammatory disease of female pelvic organs
- Myelitis
- Pancreatitis
- Pulmonary thromboembolism
- Seizure disorder
- Syncope
- Thromboembolic disorder
Less Severe
- Arthralgias
- Arthritis
- Autoimmune hemolytic anemia
- Chills
- Cough
- Diarrhea
- General weakness
- Insomnia
- Lymphadenopathy
- Malaise
- Myalgias
- Nasal congestion
- Toothache
- Urticaria
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Hum. Papillomavirus Vac.(Gardasil)
Safety and efficacy not established in pediatrics < 9 years.
- 1 Day – 9 Years
- Safety and efficacy not established in pediatrics < 9 years.
Human Papillomavirus Vaccine(gardasil 9)
- Severity Level:
B
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Human Papillomavirus Vaccine ( Gardasil)
Compatible per the american college of obstetricians and gynecologists.
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Compatible per the american college of obstetricians and gynecologists. |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Prevention of anal cancer due to HPV | |
| Z23 | Encounter for immunization |
| Prevention of cervical cancer due to HPV | |
| Z23 | Encounter for immunization |
| Prevention of genital warts | |
| Z23 | Encounter for immunization |
| Prevention of vaginal cancer due to HPV | |
| Z23 | Encounter for immunization |
| Prevention of vulvar cancer due to HPV | |
| Z23 | Encounter for immunization |
| 0-9 | A-Z |
|---|---|
| Z23 | Encounter for immunization |
| Z23 | Encounter for immunization |
| Z23 | Encounter for immunization |
| Z23 | Encounter for immunization |
| Z23 | Encounter for immunization |
Formulary Reference Tool